|
|
|
|
| LEADER |
06492nma a2201801 u 4500 |
| 001 |
EB001974455 |
| 003 |
EBX01000000000000001137357 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
210512 ||| eng |
| 020 |
|
|
|a 9783039289240
|
| 020 |
|
|
|a 9783039289233
|
| 020 |
|
|
|a books978-3-03928-924-0
|
| 100 |
1 |
|
|a Gianni, Maria Lorella
|
| 245 |
0 |
0 |
|a Human Milk and Lactation
|h Elektronische Ressource
|
| 260 |
|
|
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2020
|
| 300 |
|
|
|a 1 electronic resource (368 p.)
|
| 653 |
|
|
|a iodine
|
| 653 |
|
|
|a milk therapy
|
| 653 |
|
|
|a breastfeeding difficulties
|
| 653 |
|
|
|a Phospholipids
|
| 653 |
|
|
|a protein
|
| 653 |
|
|
|a duration of lactation
|
| 653 |
|
|
|a growth factors
|
| 653 |
|
|
|a term
|
| 653 |
|
|
|a term infant
|
| 653 |
|
|
|a potassium
|
| 653 |
|
|
|a antioxidants
|
| 653 |
|
|
|a carotenoids
|
| 653 |
|
|
|a infant formula
|
| 653 |
|
|
|a nervonic acid
|
| 653 |
|
|
|a Human Milk
|
| 653 |
|
|
|a bile salt stimulated lipase
|
| 653 |
|
|
|a donor human milk
|
| 653 |
|
|
|a dietary intake
|
| 653 |
|
|
|a mothers' own milk
|
| 653 |
|
|
|a nutrition
|
| 653 |
|
|
|a donor milk
|
| 653 |
|
|
|a targeted metabolomics
|
| 653 |
|
|
|a flow injection analysis
|
| 653 |
|
|
|a antenatal
|
| 653 |
|
|
|a body composition
|
| 653 |
|
|
|a pregnancy
|
| 653 |
|
|
|a nutritional status
|
| 653 |
|
|
|a vitamin D deficiency
|
| 653 |
|
|
|a copper
|
| 653 |
|
|
|a proteases
|
| 653 |
|
|
|a breastfeeding
|
| 653 |
|
|
|a protective factors
|
| 653 |
|
|
|a country
|
| 653 |
|
|
|a magnesium
|
| 653 |
|
|
|a sodium
|
| 653 |
|
|
|a phosphocholine
|
| 653 |
|
|
|a selenium
|
| 653 |
|
|
|a amino acids
|
| 653 |
|
|
|a neonate
|
| 653 |
|
|
|a infant
|
| 653 |
|
|
|a macronutrients
|
| 653 |
|
|
|a celiac disease
|
| 653 |
|
|
|a Biology, life sciences / bicssc
|
| 653 |
|
|
|a antioxidant capacity
|
| 653 |
|
|
|a promotion of breastfeeding
|
| 653 |
|
|
|a phosphorus
|
| 653 |
|
|
|a Milk Fat Globule Membrane
|
| 653 |
|
|
|a colostrum
|
| 653 |
|
|
|a Preterm infant
|
| 653 |
|
|
|a storage
|
| 653 |
|
|
|a term infants
|
| 653 |
|
|
|a prematurity
|
| 653 |
|
|
|a adipokines
|
| 653 |
|
|
|a 2?-fucosyllactose (2?FL)
|
| 653 |
|
|
|a pumping
|
| 653 |
|
|
|a lipid metabolites
|
| 653 |
|
|
|a human milk fat
|
| 653 |
|
|
|a 3?-sialyllactose (3?SL)
|
| 653 |
|
|
|a ?-tocopherol
|
| 653 |
|
|
|a LC-MS
|
| 653 |
|
|
|a early breastfeeding cessation
|
| 653 |
|
|
|a high-performance liquid chromatography (HPLC)
|
| 653 |
|
|
|a preterm
|
| 653 |
|
|
|a zinc
|
| 653 |
|
|
|a pasteurization
|
| 653 |
|
|
|a bioactive factors
|
| 653 |
|
|
|a secretor
|
| 653 |
|
|
|a ?-linolenic acid
|
| 653 |
|
|
|a docosahexaenoic acid (DHA)
|
| 653 |
|
|
|a Lewis
|
| 653 |
|
|
|a milk group
|
| 653 |
|
|
|a human milk benefits
|
| 653 |
|
|
|a human milk fortification
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a fatty acids
|
| 653 |
|
|
|a multiple source method
|
| 653 |
|
|
|a lactation
|
| 653 |
|
|
|a prospective study
|
| 653 |
|
|
|a inadequate intake
|
| 653 |
|
|
|a infants
|
| 653 |
|
|
|a choline
|
| 653 |
|
|
|a cytokines
|
| 653 |
|
|
|a arachidonic acid (ARA)
|
| 653 |
|
|
|a online
|
| 653 |
|
|
|a maternal diet
|
| 653 |
|
|
|a lactational stage
|
| 653 |
|
|
|a carbohydrate
|
| 653 |
|
|
|a human milk
|
| 653 |
|
|
|a endogenous peptide
|
| 653 |
|
|
|a n-9 fatty acid
|
| 653 |
|
|
|a Lipidomics
|
| 653 |
|
|
|a undernourishment
|
| 653 |
|
|
|a eicosapentaenoic acid
|
| 653 |
|
|
|a hormones
|
| 653 |
|
|
|a lactating women
|
| 653 |
|
|
|a late preterm
|
| 653 |
|
|
|a lactose
|
| 653 |
|
|
|a passive immunization
|
| 653 |
|
|
|a breast milk
|
| 653 |
|
|
|a glycoprotein
|
| 653 |
|
|
|a immune-active proteins
|
| 653 |
|
|
|a protease inhibitors
|
| 653 |
|
|
|a omega-3 fatty acids
|
| 653 |
|
|
|a fat
|
| 653 |
|
|
|a mammary gland
|
| 653 |
|
|
|a mothers
|
| 653 |
|
|
|a growth
|
| 653 |
|
|
|a supplementation
|
| 653 |
|
|
|a docosahexaenoic acid
|
| 653 |
|
|
|a calcium
|
| 653 |
|
|
|a food frequency questionnaire
|
| 653 |
|
|
|a human milk oligosaccharides (HMO)
|
| 653 |
|
|
|a iron
|
| 653 |
|
|
|a high pressure processing
|
| 653 |
|
|
|a clinical trial
|
| 653 |
|
|
|a breastfeeding support
|
| 653 |
|
|
|a eicosapentaenoic acid (EPA)
|
| 653 |
|
|
|a milk banking
|
| 653 |
|
|
|a retinol
|
| 653 |
|
|
|a expressing
|
| 653 |
|
|
|a disialyllacto-N-tetraose (DSLNT)
|
| 653 |
|
|
|a dietary assessment
|
| 653 |
|
|
|a maternal immunoglobulins
|
| 653 |
|
|
|a digestive tract
|
| 653 |
|
|
|a flu vaccine
|
| 653 |
|
|
|a video instruction
|
| 653 |
|
|
|a lipids
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by-nc-nd/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-03928-924-0
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/49630
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/2329
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 140
|
| 520 |
|
|
|a Human milk is uniquely tailored to meet infants' specific nutritional requirements. However, it is more than just "milk". This dynamic and bioactive fluid allows mother-infant signalling over lactation, guiding the infant in the developmental and physiological processes. It exerts protection and life-long biological effects, playing a crucial role in promoting healthy growth and optimal cognitive development. The latest scientific advances have provided insight into different components of human milk and their dynamic changes over time. However, the complexity of human milk composition and the synergistic mechanisms responsible for its beneficial health effects have not yet been unravelled. Filling this knowledge gap will shed light on the biology of the developing infant and will contribute to the optimization of infant feeding, particularly that of the most vulnerable infants. Greater understanding of human milk will also help in elucidating the best strategies for its storage and handling. The increasing knowledge on human milk's bioactive compounds together with the rapidly-advancing technological achievements will greatly enhance their use as prophylactic or therapeutic agents. The current Special Issue aims to welcome original works and literature reviews further exploring the complexity of human milk composition, the mechanisms underlying the beneficial effects associated with breastfeeding, and the factors and determinants involved in lactation, including its promotion and support.
|